Think Forward with Clarivate AI
Searching for the latest news and insights on the red-hot topic of Artificial Intelligence?? Look no further than the Think Forward with Clarivate AI monthly newsletter.
Clarivate launches Innovation Incubator and announces acquisition of Alethea, an AI-powered student content engagement tool?
Clarivate is debuting an Innovation Incubator for the academia and government sectors. The Incubator will introduce novel solutions for academic users and customers to drive innovation, utilizing AI. Its first program focuses on realizing better outcomes and student success through the acquisition of Alethea, a content engagement platform for students. The platform leverages AI to facilitate academic texts, class readings, and assignments through personalized and adaptive guidance.??
How is AI revolutionizing life sciences and healthcare? Hear one expert’s view.?
There are projections that the global market for AI in life sciences and healthcare will be $6.7 billion by 2030. Indeed, the transformative aspect of Gen AI is already being felt in areas such as pharmaceutical research, precision medicine and even robotic surgery. In a podcast conversation, Henry Levy – President, Life Sciences & Healthcare at Clarivate, discusses what’s driving this remarkable growth and explains what AI will and won’t enable us to achieve in improving patient outcomes.?
New AI-driven tool tracks and predicts IP costs more accurately and efficiently
Clarivate has launched a cost forecasting and budgeting tool designed to help intellectual property (IP) professionals confidently and efficiently optimize their IP portfolios and strategy. The new tool, called Forecast, gives users powerful capabilities for predictive budget forecasting. Forecast is fully integrated with IPfolio, a leading IP management system that automates and simplifies the process of enabling faster budget approvals.??
领英推荐
Report highlights life science and healthcare companies leveraging AI and ML to tackle issues in drug development?
In its annual Companies to Watch report, Clarivate has identified seven life sciences companies trying to change the drug and development paradigm by using innovative AI and machine learning? technologies. The report explores why Clarivate believes these innovators stand out and what makes them companies to watch. A key finding: the U.S. and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery.?
News release: “Seven AI/ML for life sciences companies identified as innovators in new Clarivate Companies to Watch report”
A work of art created without human input cannot be copyrighted under U.S. law, court rules?
Only works of art by human authors, not those created by artificial intelligence, can be copyrighted under U.S. law, a federal court says. The late-August ruling by the Washington, D.C. court affirms the rejection of an application filed by Stephen Thaler, a computer scientist, on behalf of his AI-system. In addition to the U.S. case, Thaler has also applied for AI-generated patents in the U.K., South Africa, Australia and Saudi Arabia, with limited success.??
News article: “AI-generated art cannot receive copyrights, US court says”?
Millions of people have trouble accessing prescriptions for critical drugs: AI could help.???
Tech expert Dr. Jo Varshney writes that AI and machine learning could help solve drug shortages. Her company is working to speed up drug development and discovery by using AI to test therapeutic combinations and determine which compounds work best together and which will cause side effects. Similarly, Clarivate has tapped its connected data lakes in its Cortellis product line, using machine learning to predict clinical trial progression and regulatory approvals.?
Network Engineer
1 年Already I apply the career page
Network Engineer
1 年If there is any opening